Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -3.20 (-3.10%)
Bid:
100.00
Ask:
102.00
Spread: 2.00 (2.00%)
Market Cap: £163.94m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Board changes

30 Nov 2022 07:00

RNS Number : 9965H
Synthomer PLC
30 November 2022
 

 

30th November 2022

 

Synthomer plc

 

Board changes

 

Synthomer plc ('Synthomer' or 'the Company') announces that it has appointed Anant Prakash as Chief Counsel and Company Secretary. Anant will join Synthomer on 1st December 2022, succeeding Richard Atkinson who will retire at the end of February 2023 following a handover period. 

 

Anant has spent the last five years at Ultra Electronics Group, latterly as General Counsel, Europe and Asia Pacific. Before joining Ultra, Anant worked at the international law firm Slaughter and May, and has experience in M&A, JVs, private equity, compliance, corporate governance and global investigations. He holds an undergraduate degree in History, a graduate Diploma in Law and a Postgraduate Diploma in Legal Practice. 

 

Cynthia Dubin has resigned as Non-Executive Director and Chair of Audit Committee as of 29 November 2022. Ian Tyler, who joined the Board as a Non-Executive Director in June 2022 as a very experienced NED and following a distinguished executive career, will succeed Cynthia as Chair of Audit Committee. 

 

Brendan Connolly, Senior Independent Director, will retire from the Board in April 2023 after nine years' service. At that point, Ian Tyler will also succeed him as Senior Independent Director. Holly Van Deursen, who has been a Non-Executive Director and member of the Remuneration Committee since September 2018, will succeed Brendan as Chair of the Remuneration Committee. 

 

 

Caroline Johnstone, Chair of Synthomer, said:

 

"I am delighted to welcome Anant to Synthomer and we look forward to working with him to further evolve and deliver our priorities as a Board.

 

I wish Richard a long and happy retirement. Over his 24 years with Synthomer he has made a very significant contribution to the successful development of the Synthomer Group.

 

I want to thank Cynthia for her contribution to the Board and committees on which she served. Her executive and banking experience has been highly valued. 

 

We are very fortunate to have two experienced Non-Executives in Ian and Holly and I look forward to working with them both in their new roles."

 

 

For enquiries contact:

Investors: Tim Hughes, Synthomer + 44 7764 859147

 

Press: Charlie Armitstead, Teneo +44 7703 330269

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIBDBISDDGDC
Date   Source Headline
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue
7th Sep 20237:00 amRNSHalf-year results
18th Jul 20237:00 amRNSPost-close trading update
12th Jul 20233:17 pmRNSAppointment of Non-Executive Director
28th Jun 202312:37 pmRNSDirector/PDMR Shareholding
28th Jun 202312:36 pmRNSDirector/PDMR Shareholding
22nd Jun 202310:20 amRNSDirector/PDMR Shareholding
16th May 20234:00 pmRNSResult of AGM
16th May 20237:00 amRNSAGM trading update
12th May 20231:08 pmRNSDirector/PDMR Shareholding
12th May 20231:06 pmRNSDirector/PDMR Shareholding
13th Apr 202310:02 amRNSHolding(s) in Company
12th Apr 20235:52 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSRefinancing
28th Feb 20233:33 pmRNSDisposal
31st Jan 20237:00 amRNSPost-close update for the year ended 31 Dec 2022
11th Jan 202311:30 amRNSResult of General Meeting
16th Dec 202212:12 pmRNSPublication of Circular &Notice of General Meeting
13th Dec 20227:00 amRNSProposed Sale of Laminates, Films & Coated Fabrics
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSBoard changes
29th Nov 202211:16 amRNSOutcome of European Commission investigation
1st Nov 20222:53 pmRNSHolding(s) in Company
27th Oct 202210:27 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Oct 20227:00 amRNSCovenant relaxation to the end of 2023 agreed
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSInvestor Seminar
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 202210:40 amRNSDirector/PDMR Shareholding
4th Oct 202210:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.